Skip to main content
Log in

Association of IL-10 gene (−1082A>G, −819C>T and −592C>A) polymorphism and its serum level with metabolic syndrome of north Indian subjects

  • RESEARCH ARTICLE
  • Published:
Journal of Genetics Aims and scope Submit manuscript

Abstract

Metabolic syndrome (MetS) is an inflammatory disorder, in which various cytokines play important role in tilting balance towards disease state. Interleukin-10 (IL-10) is an important antiinflammatory cytokine, but its genetic polymorphisms and serum levels in Indian MetS subjects are unknown. Three IL-10 gene polymorphisms (−1082A >G (rs1800896), −819C >T (rs1800872) and −592C >A (rs1800871)) were genotyped with PCR-RFLP in MetS subjects (n = 384) and age/sex matched control subjects (n = 386). Serum IL-10 was measured using enzyme-linked immunosorbent assay. Serum IL-10 level was significantly low in MetS subject and significantly correlated with clinicobiochemical parameters of MetS. Of three investigated promoter polymorphisms, IL-10 –819C > T and –592C >A were significantly associated with risk of MetS. The mutant alleles −819T and −592A of IL-10 gene polymorphism were significantly higher in MetS subjects compared to controls. Of the four different haplotypes obtained, common ACC haplotype and rare GTA haplotype of IL-10 polymorphisms were associated with MetS. The mean of fasting insulin and HOMA-IR were significantly different between the genotypes of both −819 C >T and −592C >A polymorphisms of IL-10 in MetS subjects. These results suggested that polymorphisms in IL-10 gene (−819C >T and −592C >A), haplotypes (ACC and GTA) and serum level are significantly associated with risk of MetS. IL-10 −819C >T and −592C >A polymorphic variants are also significantly associated with insulin level and homeostasis model assessment-insulin resistance in north Indian MetS subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Similar content being viewed by others

References

  • Autschbach F., Braunstein J., Helmke B., Zuna I., Schürmann G., Niemir Z. I. et al. 1998 In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease. Am. J. Pathol. 153, 121–130.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Aydıngöz I. E., Kanmaz-Özer M., Gedikbaşi A., Vural P., Doğru-Abbasoğlu S. and Uysal M. 2015 The combination of tumour necrosis factor- α −308A and interleukin-10 −1082G gene polymorphisms and increased serum levels of related cytokines: susceptibility to vitiligo. Clin. Exp. Dermatol. 40, 71–77.

    Article  PubMed  Google Scholar 

  • Babu B. M., Reddy B. P., Priya V. H., Munshi A., Rani H. S., Latha G. S. et al. 2012 Cytokine gene polymorphisms in the susceptibility to acute coronary syndrome. Genet. Test. Mol. Biomarkers 16, 359–365.

    Article  PubMed  Google Scholar 

  • Barrett J. C., Fry B., Maller J. and Daly M. J. 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265.

    Article  CAS  PubMed  Google Scholar 

  • Calcaterra V., De Amici M., Klersy C., Torre C., Brizzi V., Scaglia F. et al. 2009 Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents. Acta Biomed. 80, 117–123.

    PubMed  Google Scholar 

  • Chatterjee R., Batra J., Kumar A., Mabalirajan U., Nahid S., Niphadkar P. V. et al. 2005 Interleukin-10 promoter polymorphisms and atopic asthma in north Indians. Clin. Exp. Allergy 35, 914–919.

    Article  CAS  PubMed  Google Scholar 

  • Chen T. K., Lee J. H., Yu H. H., Yang Y. H., Wang L. C., Lin Y. T. et al. 2012 Association between human IL-10 gene polymorphisms and serum IL-10 level in patients with food allergy . J. Formos. Med. Assoc. 111, 686–692.

    Article  CAS  PubMed  Google Scholar 

  • Choi K. M., Ryu O. H., Lee K. W., Kim H. Y., Seo J. A., Kim S. G. et al. 2007 Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res. Clin. Pract. 75, 235–240.

    Article  CAS  PubMed  Google Scholar 

  • Chou C. Y., Lang H. F., Sheu W. H. and Lin J. Y. 2013 Weight loss improves serum mediators and metabolic syndrome features in android obese subjects. Obes. Res. Clin. Pract. 7, e81–e88.

    Article  PubMed  Google Scholar 

  • Després J. P. and Lemieux I. 2006 Abdominal obesity and metabolic syndrome. Nature 14, 881–887.

    Article  Google Scholar 

  • Donath M. Y. and Shoelson S. E. 2011 Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98–107.

    Article  CAS  PubMed  Google Scholar 

  • Erdogan M., Cetinkalp S., Ozgen A. G., Saygili F., Berdeli A. and Yilmaz C. 2012 Interleukin-10 (−1082G/A) gene polymorphism in patients with type 2 diabetes with and without nephropathy. Genet. Test. Mol. Biomarkers 16, 91–94.

    Article  CAS  PubMed  Google Scholar 

  • Eskdale J., Kube D., Tesch H. and Gallagher G. 1997 Mapping of the human IL-10 gene and further characterization of the 5 flanking sequence. Immunogenetics 46, 120–128.

    Article  CAS  PubMed  Google Scholar 

  • Eskdale J., Gallagher G., Verweij C. L., Keijsers V., Westendrotp R. G. and Huizinga T. W. 1998 Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc. Natl. Acad. Sci. USA 95, 9465–9470.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Eskdale J., Keijsers V., Huizinga T. and Gallagher G. 1999 Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun. 1, 151–155.

    Article  CAS  PubMed  Google Scholar 

  • Esposito K., Pontillo A., Giugliano F., Giugliano G., Marfella R., Nicoletti G. et al. 2003 Association of low interleukin-10 levels with the metabolic syndrome in obese women. J. Clin. Endocrinol. Metab. 88, 1055–1058.

    Article  CAS  PubMed  Google Scholar 

  • Friedewald W. T., Levy R. I. and Fredrickson D. S. 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502.

    CAS  PubMed  Google Scholar 

  • Grundy S. M. 1999 Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am. J. Cardiol. 83, 25F–29F.

    Article  CAS  PubMed  Google Scholar 

  • Grundy S. M., Cleeman J. I., Daniels S. R., Donato K. A., Eckel R. H., Franklin B. A. et al. 2005 Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation 112, 2735–2752.

    Article  PubMed  Google Scholar 

  • Han X., Kitamoto S., Lian Q. and Boisvert W. A. 2009 Interleukin-10 facilitates both cholesterol uptake and efflux in macrophages. J. Biol. Chem. 284, 32950–32958.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Han X., Kitamoto S., Wang H. and Boisvert W. A. 2010 Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice. FASEB J. 24, 2869–2880.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Heeschen C., Dimmeler S., Hamm C. W., Fichtlscherer S., Boersma E., Simoons M. L. et al. 2003 Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107, 2109–2114.

    Article  CAS  PubMed  Google Scholar 

  • Hotamisligil G. S. 2006 Inflammation and metabolic disorders. Nature 14, 860–867.

    Article  Google Scholar 

  • Howard M. and O’Garra A. 1992 Biological properties of interleukin 10. Immunol. Today 13, 198–200.

    Article  CAS  PubMed  Google Scholar 

  • Hussein Y. M., Alzahrani S. S., Alharthi A. A., Ghonaim M. M., Alhazmi A. S., Eed E. M. et al. 2014 Association of serum cytokines levels, interleukin 10 −1082G/A and interferon- γ +874T/A polymorphisms with atopic asthma children from Saudi Arabia. Cell Immunol. 289, 21–26.

    Article  CAS  PubMed  Google Scholar 

  • Ide A., Kawasaki E., Abiru N., Sun F., Fukushima T., Ishii R. et al. 2003 Interleukin-10 gene promoter region polymorphisms in patients with type 1 diabetes and autoimmune thyroid disease. Ann. N. Y. Acad. Sci. 1005, 344–347.

    Article  CAS  PubMed  Google Scholar 

  • Jeyaseelan L. and Rao P. S. 1989 Methods for determining sample size in clinical trials. Indian Pediatr. 26, 115–121.

    CAS  PubMed  Google Scholar 

  • Ji J. D., Tassiulas I., Park-Min K. H., Aydin A., Mecklenbrauker I., Tarakhovsky A. et al. 2003 Inhibition of interleukin-10 signaling after Fc receptor ligation and during rheumatoid arthritis. J. Exp. Med. 197, 1573–1583.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kingo K., Kõks S., Silm H. and Vasar E. 2003 IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes Immun. 4, 455–457.

    Article  CAS  PubMed  Google Scholar 

  • Kung W. J., Lin C. C., Liu S. H. and Chaung H. C. 2010 Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy. Diabetes Technol. Ther. 12, 809–813.

    Article  CAS  PubMed  Google Scholar 

  • Lech-Maranda E., Baseggio L., Bienvenu J., Charlot C., Berger F., Rigal D. et al. 2004 Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood 103, 3529–3534.

    Article  CAS  PubMed  Google Scholar 

  • Lee M. S., Wogensen L., Shizuru J., Oldstone M. B. and Sarvetnick N. 1994 Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J. Clin. Invest. 93, 1332–1338.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee M. S., Mueller R., Wicker L. S., Peterson L. B. and Sarvetnick N. 1996 IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J. Exp. Med. 183, 2663–2668.

    Article  CAS  PubMed  Google Scholar 

  • Lu M. Y., Lakkakula B. V., Liao Y. C., Tsai P. C., Yang Y. H. and Juo S. H. 2011 Lack of association between the IL-10 gene polymorphisms and features of the metabolic syndrome. J. Investig. Med. 59, 267–271.

    Article  PubMed  Google Scholar 

  • Madeshiya A. K., Singh S., Dwivedi S., Saini K. S., Singh R., Tiwari S. et al. 2015 Monocyte chemoattractant protein-1 gene polymorphism and its serum level have an impact on anthropometric and biochemical risk factors of metabolic syndrome in Indian population. Int. J. Immunogenet. 42, 78–86.

    Article  CAS  PubMed  Google Scholar 

  • Manigrasso M. R., Ferroni P., Santilli F., Taraborelli T., Guagnano M. T., Michetti N. et al. 2005 Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. J. Clin. Endocrinol. Metab. 90, 5876–5879.

    Article  CAS  PubMed  Google Scholar 

  • Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F. and Turner R. C. 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.

    Article  CAS  PubMed  Google Scholar 

  • Mohebbatikaljahi H., Menevse S., Yetkin I. and Demirci H. 2009 Study of interleukin-10 promoter region polymorphisms (−1082A/G, −819T/C and −592A/C) in type 1 diabetes mellitus in Turkish population. J. Genet. 88, 245–248.

    Article  PubMed  Google Scholar 

  • Mok C. C., Lanchbury J. S., Chan D. W. and Lau C. S. 1998 Interleukin-10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum. 41, 1090–1095.

    Article  CAS  PubMed  Google Scholar 

  • Pakala S. V., Kurrer M. O. and Katz J. D. 1997 T helper 2 (Th2) cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 186, 299–306.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pereira V. A., Sánchez-Arcila J. C., Teva A., Perce-da-Silva D. S., Vasconcelos M. P., Lima C. A. et al. 2015 IL10A genotypic association with decreased IL-10 circulating levels in malaria infected individuals from endemic area of the Brazilian Amazon. Malar. J. 14, 1–12.

    Article  Google Scholar 

  • Pinderski Oslund L. J., Hedrick C. C., Olvera T., Hagenbaugh A., Territo M., Berliner J. A. et al. 1999 Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 19, 2847–2853.

    Article  CAS  PubMed  Google Scholar 

  • Pooja S., Francis A., Bid H. K., Kumar S., Rajender S., Ramalingam K. et al. 2011 Role of ethnic variations in TNF- α and TNF- β polymorphisms and risk of breast cancer in India. Breast Cancer Res. Treat. 126, 739–747.

    Article  CAS  PubMed  Google Scholar 

  • Ramachandran A., Snehalatha C., Satyavani K., Sivasankari S. and Vijay V. 2003 Metabolic syndrome in urban Asian Indian adults—a population study using modified ATP III criteria. Diabetes Res. Clin. Pract. 60, 199–204.

    Article  CAS  PubMed  Google Scholar 

  • Reinhold D., Ansorge S. and Schleicher E. D. 1996 Elevated glucose levels stimulate transforming growth factor-beta 1 (TGF-beta 1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells. Horm. Metab. Res. 28, 267–270.

    Article  CAS  PubMed  Google Scholar 

  • Roh J. W., Kim M. H., Seo S. S., Kim S. H., Kim J. W., Park N. H. et al. 2002 Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women. Cancer Lett. 184, 57–63.

    Article  CAS  PubMed  Google Scholar 

  • Saxena M., Agrawal C. C., Bid H. K. and Banerjee M. 2012 An interleukin-10 gene promoter polymorphism (2592A/C) associated with type 2 diabetes: a north Indian study. Biochem. Genet. 50, 549–559.

    Article  CAS  PubMed  Google Scholar 

  • Scarpelli D., Cardellini M., Andreozzi F., Laratta E., Hribal M. L., Marini M. A. et al. 2006 Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects. Diabetes 55, 1529–1533.

    Article  CAS  PubMed  Google Scholar 

  • Seo K. W., Kim D. H., Sohn S. K., Lee N. Y., Chang H. H., Kim S. W. et al. 2005 Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation. Bone Marrow Transpl. 36, 1089–1095.

    Article  CAS  Google Scholar 

  • Shibata M., Endo S., Inada K., Kuriki S., Harada M., Takino T. et al. 1997 Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J. Interf. Cytok. Res. 17, 145–150.

    Article  CAS  Google Scholar 

  • Singhal P., Kumar A., Bharadwaj S., Hussain S. and Bharadwaj M. 2015 Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma. Tumour Biol. 36, 2287–2298.

    Article  CAS  PubMed  Google Scholar 

  • Straczkowski M., Kowalska I., Nikolajuk A., Krukowska A. and Gorska M. 2005 Plasma interleukin-10 concentration is positively related to insulin sensitivity in young healthy individuals. Diabetes Care 28, 2036–2037.

    Article  CAS  PubMed  Google Scholar 

  • Sun F., Sun Y., Zhang D., Zhang J., Song B. and Zheng H. 2010 Association of interleukin-10 gene polymorphism with cachexia in Chinese patients with gastric cancer. Ann. Clin. Lab. Sci. 40, 149–155.

    CAS  PubMed  Google Scholar 

  • Trayhurn P. 2005 Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol. Scand. 184, 285–293.

    Article  CAS  PubMed  Google Scholar 

  • Tsiavou A., Hatziagelaki E., Chaidaroglou A., Manginas A., Koniavitou K., Degiannis D. et al. 2004 TNF- α, TGF- β1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus. J. Clin. Immunol. 24, 591–599.

    Article  CAS  PubMed  Google Scholar 

  • Turner D. M., Williams D. M., Sankaran D., Lazarus M., Sinnott P. J. and Hutchinson I. V. 1997 An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 24, 1–8.

    Article  CAS  PubMed  Google Scholar 

  • Van Dyke A. L., Cote M. L., Wenzlaff A. S., Land S. and Schwartz A. G. 2009 Cytokine SNPs: comparison of allele frequencies by race and implications for future studies. Cytokine 46, 236–244.

  • van Exel E., Gussekloo J., de Craen A. J., Bootsma-van der Wiel A., Frölich M. and Westendorp R. G. 2002b Inflammation and stroke: the Leiden 85-Plus Study. Stroke 33, 1135–1138.

  • van Exel E., Gussekloo J, de Craen A. J., Frolich M., Bootsma-Van Der Wiel A. and Westendorp R. G. 2002a Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus Study. Diabetes 51, 1088–1092.

  • Varely H., Gowenlock A. H. and Bell M. 1980 Blood glucose and its determination. In Practical clinical biochemistry, 5th edition, vol. 1, pp. 491–494. William Heinemann Medical Book Ltd., London, UK.

    Google Scholar 

  • Vikram N. K., Misra A., Pandey R. M., Dwivedi M., Luthra K., Dhingra V. et al. 2006 Association between subclinical inflammation & fasting insulin in urban young adult north Indian males. Indian J. Med. Res. 124, 677–682.

    CAS  PubMed  Google Scholar 

  • Wasir J. S., Misra A., Vikram N. K., Pandey R. M. and Gupta R. 2008 Comparison of definitions of the metabolic syndrome in adult Asian Indians. J. Assoc. Physicians India 56, 158–164.

    CAS  PubMed  Google Scholar 

  • Wisse B. E. 2004 The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J. Am. Soc. Nephrol. 15, 2792–2800.

    Article  CAS  PubMed  Google Scholar 

  • Yu Z., Liu Q., Huang C., Wu M. and Li G. 2013 The interleukin 10 –819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls. OMICS 17, 200–214.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zammiti W., Mtiraoui N., Cochery-Nouvellon E., Mahjoub T., Almawi W. Y. and Gris J. C. 2006 Association of −592C/A, −819C/T and −1082A/G interleukin-10 promoter polymorphisms with idiopathic recurrent spontaneous abortion. Mol. Hum. Reprod. 12, 771–776.

    Article  CAS  PubMed  Google Scholar 

  • Zheng D. D., Ji S. N., Chen C., Deng X. T., Su Y. M., Pan H. Y. et al. 2014 Association of interleukin-10 promotor polymorphisms with atrial fibrillation in Han Chinese. Int. J. Clin. Exp. Med. 7, 4199–4206.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors are thankful to the healthy controls and patients for participating in the study. This work was potentially supported by a grant for scientific research from the Indian Council of Medical Research, New Delhi, India (grant no. 5/4/8-3/2010-NCD-II). The authors are grateful to the Director, CSIR-Central Drug Research Institute and colleagues from Endocrinology Division, CSIR-Central Drug Research Institute, Lucknow, India. We are also thankful to the Department of Physiology and Department of Pathology, King George’s Medical University, Lucknow, India, for their support in the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to SHRADDHA SINGH.

Additional information

Corresponding editor: S. Ganesh

[Madeshiya A. K., Singh S., Dwivedi S., Konwar R., Natu S. M. and Ghatak A. 2017 Association of IL-10 gene (−1082A >G, −819C >T and −592C >A) polymorphism and its serum level with metabolic syndrome of north Indian subjects. J. Genet. 95, xx–xx]

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

MADESHIYA, A.K., SINGH, S., DWIVEDI, S. et al. Association of IL-10 gene (−1082A>G, −819C>T and −592C>A) polymorphism and its serum level with metabolic syndrome of north Indian subjects. J Genet 96, 53–64 (2017). https://doi.org/10.1007/s12041-016-0738-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12041-016-0738-7

Keywords

Navigation